Frontage Holdings Ίδια Κεφάλαια 2024

Τι κάνει η Frontage Holdings;

Frontage Holdings Corp is an international pharmaceutical and biotechnology company founded in 2001 in Pennsylvania, USA. With its wide range of services in preclinical and clinical research, Frontage offers its customers innovative and cost-effective solutions to accelerate and optimize the development of new therapeutics and drug candidates. The core business of Frontage focuses on providing services in the areas of pharmacology, pharmacokinetics, toxicology, preclinical development, clinical development, and bioanalytical laboratory services. The company operates research laboratories in the USA and China and has extensive experience in collaborating with customers from the pharmaceutical and biotechnology industry, as well as academic institutions. Frontage has become a major pharmaceutical and biotechnology company serving customers in the USA, Europe, and Asia. As such, Frontage has become a key partner for companies looking to advance their drug candidates through the clinical phases of development. Frontage offers targeted and tailored services to meet the requirements of each project and can support customers in the rapid and cost-effective implementation of their goals. The various divisions of Frontage include pharmaceutical services, chemical development, bioanalysis, and DMPK (Disposition, Metabolism, Pharmacokinetics). Frontage's pharmaceutical services offer a wide range of preclinical and clinical development resources, including cell-based assays, drug metabolism and pharmacokinetic studies, as well as clinical trial management and execution. Frontage's chemical development division provides a wide range of expert services, including the synthesis of organic molecules, process development, and scalable production. Frontage's bioanalytical services offer a range of solutions for the quantitative determination of drugs and other biomolecules in biological samples such as blood and urine. This includes the use of advanced technologies such as mass spectrometry for compound identification and quantification. DMPK is an important division of Frontage, focusing on the absorption, metabolism, distribution, and excretion of drugs in the body and their occurrence in biological fluids such as blood and urine. Frontage utilizes its expertise in DMPK to help its customers optimize drug concentrations in the bloodstream and achieve optimal efficacy. Frontage has continuously expanded its services to meet the growing demands of the industry. The company has also focused on providing innovative technologies that can enhance the efficiency and accuracy of research and development. Frontage works closely with its customers to develop customized solutions that meet their specific requirements. Frontage has a proud history as a trusted partner in the pharmaceutical and biotechnology industry, offering its customers high-quality and reliable services. Through its effective and innovative research and development, Frontage supports its customers in the development of drugs that can help improve the lives of people worldwide. Frontage Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.